P&F Wraps Up TCT 2026 in San Diego
November 2026
P&F Products & Features joined the interventional cardiology community at TCT 2026, held Oct. 31 – Nov. 3 at the San Diego Convention Center.
This year’s program featured five TricValve® presentations by investigators from Europe, Asia, and the United States:
- Durability and Outcomes of TricValve Bicaval Therapy: Mid- and Long-Term TRICUS Registry Follow-up, presented by Philipp Nikolai, MD
- Bicaval Valve Implantation With TricValve in Chinese Patients With Severe Tricuspid Regurgitation, presented by Yuan Zhang, MD
- Integrated Use of Echocardiography and CT in the TRICAV I Early Feasibility Study, presented by Nadira Hamid, MD
- Challenging Case: Jailed, but Unharmed — Bicaval TricValve Implantation With Multiple Pre-Existing Leads, presented by John Saxon, MD, in Cases with the Masters
- CT-Based Assessment of Right Heart Remodeling After Bicaval TricValve Implantation, presented by Yuan Zhang, MD
At Booth #4118, physicians and industry colleagues explored the TricValve system up close through hands-on benchtop demonstrations and conversations with TricValve experts.
P&F thanks the presenting investigators, everyone who visited the booth, and the Cardiovascular Research Foundation for another outstanding meeting.
CAUTION: The TricValve system is limited by U.S. Federal Law to investigational use. TricValve is MDR CE marked and registered with ANVISA.
